EMA Handed Down Fewer Positive Drug Opinions in 2018
01/10/2019
In 2018, the European Medicines Agency (EMA) recommended marketing authorization for 84 new medicines, down from 92 in 2017, according to a report in Medscape.
The 84 medicines given a thumbs up by EMA’s Committee for Medicinal Products for Human Use include 42 agents with a new active substance never before authorized in the European Union (EU).
“Many of these medicines represent a significant improvement in their therapeutic areas; they include medicines for children, for rare diseases and advanced therapies,” the agency said in a report released January 4.